相关实验视频

Updated: May 21, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

在黑色素瘤大脑转移中,NK细胞将免疫检查点阻断免疫疗法和反应联系起来

Gary Kohanbash^1,2,3, Stephen C Frederico^4,3, Itay Raphael^4,3

¹Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA gary.kohanbash2@chp.edu.

Journal for immunotherapy of cancer

|March 19, 2025

概括

针对黑色素瘤脑转移的免疫检查点阻塞 (ICB) 疗法涉及自然杀手 (NK) 细胞. 这些NK细胞通过招募CD8T细胞来增强抗瘤免疫力,而不是直接杀死瘤.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
神经科学是一个神经科学.

背景情况:

黑色素瘤大脑转移 (BMs) 是一个重大的临床挑战.
免疫检查点封锁 (ICB) 在治疗BM方面表现有前途,但其精确的机制仍在被阐明.
了解这些机制对于优化治疗策略至关重要.

研究的目的:

探索自然杀手 (NK) 细胞在ICB治疗黑色素瘤BM的疗效中的作用.
在ICB后的瘤微环境中研究NK细胞的非正规功能.
为了深入了解ICB的复杂机制,而不仅仅是直接的T细胞中介细胞毒性.

主要方法:

菲夫等人最近的一项研究的分析. 专注于用ICB治疗的黑色素瘤BM中的NK细胞活性.
检查NK细胞的化学激素释放及其对其他免疫细胞的影响.
评估CD8 T细胞招募和整体抗瘤免疫反应.

主要成果:

针对黑色素瘤BMs的ICB治疗激活NK细胞.
NK细胞释放化学因子,这些化学因子将CD8 T细胞招募到瘤部位.
这种NK细胞介导的招募增强了抗瘤免疫力,表明其作用超出了直接杀死.

结论:

NK细胞在黑色素瘤BMs的ICB疗效中发挥着关键的,非正规的作用.
ICB机制涉及NK细胞驱动的CD8T细胞的招募,增强抗瘤反应.
这些发现扩大了我们对ICB在脑瘤微环境中的复杂作用的理解.

关键词:

中枢神经系统癌症中枢神经系统癌症免疫检查点抑制剂免疫检查点抑制剂自然杀手 - - NK - - 是一种自然杀手.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...